ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

ACMG Secondary Findings Working Group

doi:10.1016/j.gim.2022.04.006

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

ACMG Secondary Findings Working Group

Research output: Contribution to journal › Editorial

131 Scopus citations

Original language	English
Pages (from-to)	1407-1414
Number of pages	8
Journal	Genetics in Medicine
Volume	24
Issue number	7
DOIs	https://doi.org/10.1016/j.gim.2022.04.006
State	Published - Jul 2022

Keywords

Exome sequencing
Genome sequencing
Incidental findings
Secondary findings

Access to Document

10.1016/j.gim.2022.04.006

Cite this

@article{0e3137d8a6c848148680285644baf7ce,

title = "ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)",

keywords = "Exome sequencing, Genome sequencing, Incidental findings, Secondary findings",

author = "{ACMG Secondary Findings Working Group} and Miller, {David T.} and Kristy Lee and Abul-Husn, {Noura S.} and Amendola, {Laura M.} and Kyle Brothers and Chung, {Wendy K.} and Gollob, {Michael H.} and Gordon, {Adam S.} and Harrison, {Steven M.} and Hershberger, {Ray E.} and Klein, {Teri E.} and Richards, {Carolyn Sue} and Stewart, {Douglas R.} and Martin, {Christa Lese}",

note = "Funding Information: Funding and support listed here did not support development of this document unless included in the Acknowledgments section. N.S.A.-H. was previously employed by the Regeneron Genetics Center, has received an honorarium from Genentech, and is a member of the scientific advisory board of Allelica, Inc. W.K.C. is a member of the scientific advisory board of Regeneron Genetics Center. D.T.M. has received honoraria from Ambry Genetics and PreventionGenetics LLC. D.R.S. is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, Rockville, MD, United States, and also performs contract clinical telehealth services for Genome Medical, Inc in accordance with relevant National Cancer Institute ethics policies. All other authors declare no conflicts of interest. Funding Information: Funding and support listed here did not support development of this document unless included in the Acknowledgments section. N.S.A.-H. was previously employed by the Regeneron Genetics Center, has received an honorarium from Genentech, and is a member of the scientific advisory board of Allelica, Inc. W.K.C. is a member of the scientific advisory board of Regeneron Genetics Center. D.T.M. has received honoraria from Ambry Genetics and PreventionGenetics LLC. D.R.S. is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute , Rockville, MD, United States, and also performs contract clinical telehealth services for Genome Medical, Inc in accordance with relevant National Cancer Institute ethics policies. All other authors declare no conflicts of interest. ",

year = "2022",

month = jul,

doi = "10.1016/j.gim.2022.04.006",

language = "English",

volume = "24",

pages = "1407--1414",

journal = "Genetics in Medicine",

issn = "1098-3600",

publisher = "Elsevier BV",

number = "7",

}

TY - JOUR

T1 - ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing

T2 - A policy statement of the American College of Medical Genetics and Genomics (ACMG)

AU - ACMG Secondary Findings Working Group

AU - Miller, David T.

AU - Lee, Kristy

AU - Abul-Husn, Noura S.

AU - Amendola, Laura M.

AU - Brothers, Kyle

AU - Chung, Wendy K.

AU - Gollob, Michael H.

AU - Gordon, Adam S.

AU - Harrison, Steven M.

AU - Hershberger, Ray E.

AU - Klein, Teri E.

AU - Richards, Carolyn Sue

AU - Stewart, Douglas R.

AU - Martin, Christa Lese

N1 - Funding Information: Funding and support listed here did not support development of this document unless included in the Acknowledgments section. N.S.A.-H. was previously employed by the Regeneron Genetics Center, has received an honorarium from Genentech, and is a member of the scientific advisory board of Allelica, Inc. W.K.C. is a member of the scientific advisory board of Regeneron Genetics Center. D.T.M. has received honoraria from Ambry Genetics and PreventionGenetics LLC. D.R.S. is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, Rockville, MD, United States, and also performs contract clinical telehealth services for Genome Medical, Inc in accordance with relevant National Cancer Institute ethics policies. All other authors declare no conflicts of interest. Funding Information: Funding and support listed here did not support development of this document unless included in the Acknowledgments section. N.S.A.-H. was previously employed by the Regeneron Genetics Center, has received an honorarium from Genentech, and is a member of the scientific advisory board of Allelica, Inc. W.K.C. is a member of the scientific advisory board of Regeneron Genetics Center. D.T.M. has received honoraria from Ambry Genetics and PreventionGenetics LLC. D.R.S. is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute , Rockville, MD, United States, and also performs contract clinical telehealth services for Genome Medical, Inc in accordance with relevant National Cancer Institute ethics policies. All other authors declare no conflicts of interest.

PY - 2022/7

Y1 - 2022/7

KW - Exome sequencing

KW - Genome sequencing

KW - Incidental findings

KW - Secondary findings

UR - http://www.scopus.com/inward/record.url?scp=85134425915&partnerID=8YFLogxK

U2 - 10.1016/j.gim.2022.04.006

DO - 10.1016/j.gim.2022.04.006

M3 - Editorial

C2 - 35802134

AN - SCOPUS:85134425915

SN - 1098-3600

VL - 24

SP - 1407

EP - 1414

JO - Genetics in Medicine

JF - Genetics in Medicine

IS - 7

ER -